L&K Bio Successfully Performs 2-Level Spinal Implant Surgery... "Will Split $1 Trillion US Lateral Insertion Cage Market"

AccelFix-XL Level 2 Surgery Success
Curved Inserter Developed for Level 3 Surgery
Competition with Globus Medical for Lateral Insertion Cage Intensifies

[Asia Economy Reporter Hyungsoo Park] L&K Bio, a developer of spinal implants, announced on the 7th that it has successfully completed the second surgery in the United States using the laterally inserted height-expandable interbody fusion device, ‘XL Cage’.

A company representative explained, "The previous surgery was a single-level procedure replacing the disc between the 3rd and 4th lumbar vertebrae (L3/L4 Disc)," adding, "The second surgery was a two-level procedure consecutively replacing the discs between the 2nd and 3rd lumbar vertebrae (L2/L3 Disc) and the 3rd and 4th lumbar vertebrae (L3/L4 Disc)."

The surgery was performed by former specialist Frederick Jeon of Bowman Hospital, a renowned neurosurgeon in the United States. Using the AccelFix-XL cage with a height of 10mm, the surgery was stably completed by expanding it to a final height of 11.5mm. The company representative introduced that it was optimized for the patient’s disc condition.

The company representative also emphasized, "Surgery on the disc between the 4th and 5th lumbar vertebrae (L4/L5 Disc) requires a curved inserter tool bent in a ‘V’ shape at the tip due to interference from the iliac bone," adding, "Recently, L&K Bio developed a ‘curved inserter’ applying Impact Ball technology, enabling three-level surgeries from the 2nd/3rd discs to the 4th/5th discs."

The U.S. lateral cage market has grown to a scale of 1 trillion KRW, led by the established player NuVasive. Recently, NuVasive failed to release a competitive expandable cage, while competitor Globus Medical launched an expandable cage.

By releasing the curved inserter essential for lateral insertion surgeries, L&K BioMed expressed its ambition to form a duopoly with Globus Medical in the 1 trillion KRW U.S. lateral cage market.

L&K Bio also obtained U.S. FDA approval for the ‘Lumbar Plate’ used together with the ‘AccelFix-XL Cage,’ thereby establishing a product lineup for lateral surgeries.

This content was produced with the assistance of AI translation services.